Dongying Tiandong Pharmaceutical Co.,Ltd

FDA inspection history in Dongying, China, 2016 to 2019

1
Close-out
1
Form 483
1
Warning letter

Every document, by year

  • Close-out
  • Form 483
  • Warning letter

2016: one warning letter; 2018: one Form 483; 2019: one close-out letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2016–19One warning letter, one Form 483 and one close-out letter, at Dongying, China.

Cited most

Across all Dongying Tiandong Pharmaceutical Co.,Ltd observations on file

The complete Dongying Tiandong Pharmaceutical Co.,Ltd file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Also: one document not tied to a site.

Documents

3 on file, newest first
DateDocumentPrice
2019-01-11Close-out Close-out letter$99
2018-10-19483 Form 483$99
2016-11-10Warning letter Warning letter$99

Investigators on these documents

Marijo B. Kambere (1)

FEI number 3004395180 · most recent document Jan 11, 2019

About Dongying Tiandong Pharmaceutical Co.,Ltd

How many FDA Form 483s has Dongying Tiandong Pharmaceutical Co.,Ltd received?

FDA Intel has 1 Form 483 on file for Dongying Tiandong Pharmaceutical Co.,Ltd; the most recent is dated Oct 19, 2018.

When was Dongying Tiandong Pharmaceutical Co.,Ltd last inspected by FDA?

The most recent FDA inspection document on file for Dongying Tiandong Pharmaceutical Co.,Ltd is a Form 483 dated Oct 19, 2018, for the site in Dongying, China.

What did FDA cite at Dongying Tiandong Pharmaceutical Co.,Ltd?

The regulations cited most in the observations on file for Dongying Tiandong Pharmaceutical Co.,Ltd are 21 CFR 211.194 (Laboratory records), 1 time.

Has Dongying Tiandong Pharmaceutical Co.,Ltd received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Dongying Tiandong Pharmaceutical Co.,Ltd; the most recent is dated Nov 10, 2016.